Chengdu KangHong Pharmaceuticals

Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in Sichuan, China. Founded in 1996, the company focuses on the research, development, manufacturing, and distribution of medicines for various therapeutic areas, including ophthalmic, central nervous, digestive, and endocrine systems. They are known for their flagship biological product, Conbercept (Lumitin), used to treat retinal diseases. Kanghong has expanded into advanced modalities like AAV-based gene therapies and antibody-drug conjugates (ADCs), and also maintains a portfolio of traditional Chinese medicines and chemical generics. The company has subsidiaries in China, Israel, and the United States.